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Copyright © 200? JCBN Summary Past studies have suggested that some carbon monoxide (CO) moves from blood
haemoglobin to tissue cells and that mitochondrial cytochrome c oxidase oxidizes CO to
carbon dioxide (CO2). However, no study has demonstrated this redistribution and oxidization
of CO under physiological conditions. The objective of this study was to trace the redistribu-
tion and oxidization of CO in the human body by detecting 13CO2 production after the
inhalation of 13CO. In Experiment 1, we asked a healthy subject to inhale 50 ppm 13CO gas.
In Experiment 2, we circulated heparinized human blood in a cardio-pulmonary bypass circuit
and supplied 50 ppm 13CO gas to the oxygenator. We sequentially sampled exhaled and output
gases and measured the 13CO2/12CO2 ratios. In Experiment 1, the exhaled 13CO2/12CO2 ratio
increased significantly between 4 to 31 h of 13CO inhalation. In Experiment 2, the output
13CO2/12CO2 ratio showed no significant increase within 36 h of 13CO input. Experiment 1
demonstrated the oxidization of CO in the human body under physiological conditions.
Experiment 2 confirmed that oxidization does not occur in the circulating blood and indicated
the redistribution of CO from blood carboxyhaemoglobin to tissue cells.
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Introduction
Since endogenous carbon monoxide (CO) production by
heme degradation was first reported in the early 1950s [1, 2],
numerous studies have revealed its physiological roles and
regulatory mechanisms [3]. However, two pathways in the
disposition and catabolism of endogenous CO remain
unidentified. One pathway is the redistribution of CO from
circulating blood to tissue cells. It is supposed that 80% of
endogenously produced CO binds to haemoglobin in the
circulating blood and is finally exhaled [4]. Although several
studies have suggested that a portion of CO moves from
blood haemoglobin to tissue and binds to intracellular
heme proteins [5–8], this redistribution of CO has not been
demonstrated under physiological conditions [3]. Another
pathway is the oxidization of CO to carbon dioxide (CO2) by
cytochrome c oxidase in mitochondria. It has been believed
that a small metabolic endpoint of endogenous CO is the
oxidization to CO2 [9] a process that has been demonstrated
in vitro [10–12]. However, in vivo oxidization of CO under
physiological conditions has not been shown [3].
The objective of this study was to trace these unidentified
redistribution and oxidization pathways of CO in the human
body through detection of 13CO2 production by exhaled gas
analysis following the inhalation of 13CO gas. 13C is a stable
isotope of 12C with an abundance ratio of 1.1%.M. Sawano and A. Shimouchi
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Experimental Procedures
The experimental protocol of this study was approved by
the ethics committee of Saitama Medical University.
Experiment 1
The subject was a healthy male adult volunteer with no
smoking habits who gave written informed consent. First,
the subject inhaled the synthesized air and exhaled into a
1.3-L gas sampling bag (Pylori exhaled gas sampling bag,
Fukuda Denshi Co., Ltd., Tokyo, Japan) after holding his
breath for 20 s. Twenty-five bags of exhaled gas were
collected as the background.
Then the subject inhaled synthesized air that contained
50 ppm 13CO gas. During this procedure, a physician closely
observed the subject and monitored his electrocardiogram,
pulse-oximetry, and blood pressure in an operating room
equipped with a forced ventilation system. Exhaled CO
and CO2 concentrations were continuously analyzed by an
electrochemical sensor (Carbolizer mBA-1000, Taiyo Co.,
Ltd., Osaka, Japan). This sensor is capable of determining
CO and CO2 concentrations every second with resolutions of
0.1 ppm and 0.1%, respectively [13]. The procedure was
terminated before the exhaled CO concentration achieved
50 ppm, which is almost equivalent to 10% blood carboxy-
haemoglobin concentration (COHb%). Following the inha-
lation of 13CO gas, exhaled gas was sampled every hour for
the first 12 h, every 2 h for the next 12 h, and thereafter
every 4 h, by the same procedure as the background. We
also sampled venous blood every 6 h to measure COHb% by
a CO-hemoximtre integrated into a blood gas analyzer
(ABL-720, Radiometer Copenhagen Co., Ltd., Copenhagen,
Denmark). In this study, we detected 13CO2 production by
measuring the increase of the 13CO2/12CO2 ratio in exhaled
gas using an infrared spectral analyzer (POCone, Otsuka
Pharmaceutical Co., Ltd., Tokyo, Japan). This analyzer is
capable of determining changes in the 13CO2/12CO2 ratio with
a resolution of 0.1 per mil (0/00) relative to the background.
A single measurement required 120 mL of sample and the
background gases, and the measurement was repeated ten
times for each sample. We terminated the experiment 36 h
after inhalation, when the elevated 13CO2/12CO2 ratio of the
sample had recovered to the background level.
Experiment 2
The objective of Experiment 2 was to ensure that the
13CO2 production shown in Experiment 1 was totally derived
from the oxidization of 13CO in tissue cells. Fig. 1 shows the
experimental device that simulates human blood circulation
and gas exchange on a 1/10 scale. We filled a CAPIOX
cardiopulmonary bypass circuit (Terumo Co., Tokyo, Japan)
with 400 mL of human whole blood, 120 ml of saline, and
1000 units of heparin. A centrifugal pump regulated the
circulating blood flow at 0.5 l/min. We infused 100% CO2
gas into the circuit to simulate tissue CO2 production.
First, we supplied synthesized air at 0.5 l/min to the
oxygenator as input gas, adjusted the infusion rate of CO2 to
maintain the output CO2 concentration between 5% and 6%,
and collected the output gas in the sampling bag as the
background. Next, we added 50 ppm 13CO to the input gas
until the carboxyhaemoglobin concentration of the blood
exceeded 10%. Then we collected output gas every 4 h for
36 h.
We measured the 13CO2/12CO2 ratios of the output gas
and the carboxyhaemoglobin concentration of the blood by
the same procedures as in Experiment 1.
Statistical processing
The significance of the increase of the 13CO2/12CO2 ratios
was statistically assessed using Student’s t test, with signifi-
cance level of 5% (p<0.05).
Results
Figs. 2 and 3 show the increase in the exhaled 13CO2/12CO2
ratios relative to the background and the blood carboxy-
haemoglobin concentrations plotted against time in Experi-
ments 1 and 2. Error bars of the 13CO2/12CO2 ratios indicate
two standard deviations or 95% confidence intervals of ten
repeated measurements.
In Experiment 1, the exhaled 13CO2/12CO2 ratio increased
significantly between 4 and 31 h after 13CO inhalation
Fig. 1. Schematic of the device used for Experiment 2. The
centrifugal pump circulates heparinized blood in a cardio-
pulmonary bypass circuit. Carbon dioxide gas is infused
into the circuit. 13CO is added to the input gas of the
oxygenator and the output gas is sampled sequentially.Redistribution and Oxidization of Carbon Monoxide
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(p<0.05). The maximum increase in the 13CO2/12CO2 ratio
was +2.10/00 of the background 9 h after inhalation. In
Experiment 2, the output 13CO2/12CO2 ratio showed no
significant increase for 36 h after the 13CO input.
Discussion
First, we ensured the subject was not subjected to
symptomatic CO intoxication in Experiment 1. The threshold
level for the carboxyhaemoglobin concentration to manifest
the mildest symptoms of CO intoxication has reported to be
10% [14, 15]. We have developed a system for non-invasive,
continuous carboxyhaemoglobin densitometry by expiratory
gas analysis that enables continuous real-time monitoring of
the carboxyhaemoglobin concentration using the Carbolizer
sensor [13]. Using this technique, we controlled the duration
of  13CO gas inhalation to limit the maximum carboxy-
haemoglobin concentration of the subject to below 10%.
In addition to the monitors equipped in the intensive care
unit of our hospital, at least two physicians continuously
monitored the subject’s consciousness and neurological status
for any unexpected manifestations during the experiment.
Over the past decade, numerous studies have clarified the
physiological role of endogenous CO as a gas transmitter
that activates or inhibits various enzymes by binding to
heme proteins within a cell or adjacent cells. However, most
researchers are sceptical about the role of CO as a trans-
organic or systemic signal transmitter, because the redistri-
bution of CO from blood carboxyhaemoglobin to tissue
cells has not been shown. It is widely accepted that the
only destination for haemoglobin-bound CO is to be
exchanged with oxygen in the lung and to be exhaled.
Previous studies have shown remnant effects of CO after
carboxyhaemoglobin elimination [5], a poor correlation of
blood carboxyhaemoglobin levels with the physiological
effects of CO inhalation [7], and a protective effect of CO
inhalation against ischemia-reperfusion injury in rats [8].
These findings suggest that a fraction of CO moves from
blood to tissue, but no tracer analysis study has demonstrated
this redistribution.
Meanwhile, several laboratories have confirmed the
oxidization of CO by mitochondrial cytochrome c oxidase
extracted from various animal organs [10–12]. However,
those studies detected CO2 production from the purified
enzyme gassed with CO in a closed chamber and no tracer
analysis study has demonstrated the oxidization of CO in
living animal tissue under physiological conditions.
In Experiment 1, we detected 13CO2 production deriving
from inhaled 13CO, which demonstrated the oxidization of
CO in a living human body under physiological conditions.
In Experiment 2, we detected no 13CO2 production, which
confirmed that oxidization does not occur in the circulating
blood. Taken together, these experiments indicate that a
portion of inhaled CO is redistributed from the blood to
tissue cells and is oxidized there.
There is still the possibility that CO oxidization occurs in
airway epithelium. Inhaled CO contacts airway epithelium
before it binds to blood haemoglobin and we may have
Fig. 2. Time course of 13CO2/12CO2 ratio and blood carboxy-
haemoglobin concentration for Experiment 1. Solid line
represents the sequential increase in the 13CO2/12CO2
ratios relative to the background (per mil, left axis).
Broken line represent the sequential measurements of the
blood carboxyhaemoglobin concentration (percentage,
right axis). The error bars indicate two standard devia-
tions or 95% confidence intervals of ten repeated mea-
surements.
Fig. 3. Time course of 13CO2/12CO2 ratio and blood carboxy-
haemoglobin concentration for Experiment 2. Solid line
represents the sequential increase in the 13CO2/12CO2
ratios relative to the background (per mil, left axis).
Broken line represents the sequential measurements of the
blood carboxyhaemoglobin concentration (percentage,
right axis). The error bars indicate two standard devia-
tions or 95% confidence intervals of ten repeated mea-
surements.M. Sawano and A. Shimouchi
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detected 13CO2 that is derived from the oxidation of CO in
the airway epithelium tissue. If the oxidization occurs in
the airway, 13CO2 production would increase during 13CO
inhalation and decrease soon after the termination of inhala-
tion. However, a significant increase in 13CO2 production
started 4 h after the termination of 13CO inhalation and
was sustained for 31 h, with a peak at 9 h in Experiment 1.
This time delay between CO inhalation and CO2 production
may reflect the time required for redistribution and thus
refuting the hypothesis of CO oxidization in the airway
epithelium. Still, further evidence is required to confirm
such CO redistribution, including the detection of 13CO2
production after infusion of 13CO-bound carboxyhaemoglobin
(13CO-saturated autologous blood).
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